# US 2023/0068937 A1 · Application of pathogenicity model and training thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0068937 A1
- Document ID: US20230068937A1
- Status: Published application
- Kind: A1
- Application number: 17/792,521
- Filed: 2021-01-15
- Published: 2023-03-02
- Earliest claimed: 2020-01-16
- Applicants: Congenica Ltd.
- Inventors: Sandro Morganella; Yacine Dahman; Laura Ponting; Emily Mackay
- Web page: https://patentgrep.com/patent/US20230068937A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B 40/20: Supervised data analysis
- G16B 45/00: ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A computer-implemented method that is for assessing pathogenicity of a variant for a patient. Receive a variant. Determine at least one probability for the variant in relation to pathogenic metrics based on a collection of learned variants. The pathogenic metrics comprise a data representation of at least one genetic condition cluster for determining at least one probability for the variant. The combined representation of at least one probability of the variant for the patient is outputted.

## Claims

### Claim 1

A computer-implemented method for assessing pathogenicity of a variant for a patient comprising:
receiving a variant;
determining at least one probability for the variant in relation to pathogenic metrics based on a collection of learned variants, wherein the pathogenic metrics comprise a data representation of at least one genetic condition cluster for determining the at least one probability for the variant; and
outputting a combined representation of the at least one probability of the variant for the patient.

### Claim 2 (depends on 1)

The computer-implemented method of claim 1, wherein the data representation of the at least one genetic condition cluster is derived from the collection of learned variants and weighted in relation to a set of phenotypic information of patients.

### Claim 3 (depends on 1)

The computer-implemented method of claim 1, wherein the variant is included in the collection of learned variants, further comprising:
receiving phenotypic information of the patient;
determining a contribution associated with each of the at least one genetic condition cluster based on the phenotypic information of the patient; and
adjusting the at least one probability for the variant based on the contribution determined in accordance with the data representation of the at least one genetic condition cluster.

### Claim 4 (depends on 2)

The computer-implemented method of claim 2, further comprising:
assessing an availability of the phenotypic information of the patient; and
determining, based on the availability, whether to adjust the at least one genetic condition cluster for outputting the combined representation.

### Claim 5 (depends on 3)

The computer-implemented method of claim 3, wherein the determining a contribution associated with each of the at least one genetic condition cluster based on the phenotypic information of the patient, further comprising:
portioning each of the at least one genetic condition cluster using one or more regression models, wherein the one or more regression models predict the contribution to each of the at least one genetic condition cluster given the phenotypic information of the patient.

### Claim 6 (depends on 1)

The computer-implemented method of claim 1, wherein the variant is not included in the collection of learned variants, further comprising:
identifying at least one proximal variant from the collection of learned variants in relation to the variant;
receiving a set of side information corresponding to each of the at least one proximal variant, wherein the set of side information comprises one or more indicators;
identifying a nearest variant based on the set of side information; and applying the nearest variant as the variant when determining the at least one probability for the variant in relation to the pathogenic metrics.

### Claim 7 (depends on 6)

The computer-implemented method of claim 6, wherein the nearest variant is identified by applying similarity metrics associated with the at least one proximal variant based on the set of side information; and/or wherein the similarity metrics are weighted in relation to the set of side information.

### Claim 8 (depends on 7)

The computer-implemented method of claim 7, when the similarity metrics identify at least one other variant from the collection of learned variants to have an equivalent similarity score, the at least one probability for the variant is determined by averaging each of the at least one proximal variant.

### Claim 9

A computer-implemented method for generating at least one genetic condition cluster for determining at least one probability of a variant in relation to pathogenic metrics comprising:
receiving annotated data of at least one patient associated with a collection of variants, wherein the annotated data comprise interpretation information with associated observations corresponding to the pathogenic metrics;
determining a data representation for the annotated data of at least one patient, wherein the data representation is derived using one or more generative models; and generating the at least one genetic condition cluster based on the data representation.

### Claim 10 (depends on 9)

The computer-implemented method of claim 9, wherein the annotated data further comprises at least one of a set of phenotypic information of patients and a set of side information.

### Claim 11 (depends on 10)

The computer implemented method of claim 10, wherein at least one of
the set of phenotypic information is associated with the interpretation information in relation to the at least one patient; and
wherein the set of side information is associated with the interpretation information in relation to the collection of variants.

### Claim 12 (depends on 10)

The computer-implemented method of claim 10, further comprising:
adjusting a set of weights associated with the at least one genetic condition cluster based on the set of phenotypic information, wherein the set of weights corresponds to a contribution of the at least one genetic condition cluster to the set of phenotypic information; and
configuring one or more regression models based on the adjusted set of weights to determine the contribution in relation to the pathogenic metrics.

### Claim 13 (depends on 10)

The computer-implemented method of claim 10, wherein the set of side information comprises a data representation of indicators associated with the collection of variants.

### Claim 14 (depends on 10)

The computer-implemented method of claim 10, wherein the set of side information is applied, when the variant is not included in the collection of variants, to identify a nearest variant from the collection of variants used for determining the at least one probability of the variant; and/or wherein the at least one probability of the variant is determined using a supervised learning framework provided the set of side information.

### Claim 15 (depends on 14)

The computer-implemented method of claim 14, wherein the variant is included in the collection of variants for updating the least one genetic condition cluster by applying annotation associated with the nearest variant.

### Claim 16 (depends on 9)

The computer-implemented method of claim 9, further comprising:
determining an optimal set of the at least one genetic condition cluster based on the annotated data; and
applying the optimal set of the at least one genetic condition cluster during prediction to determine the at least one probability of a variant in relation to the pathogenic metrics.

### Claim 17 (depends on 16)

The computer-implemented method of claim 16, wherein the optimal set of the at least one genetic condition cluster is configured to be updated iteratively with new annotated data.

### Claim 18

A computer-implemented method for assessing pathogenicity of an unknown variant for a patient using a set of side information comprising:
receiving the unknown variant, wherein the unknown variant is not identified in the collection of learned variants;
using the set of side information corresponding to each of a subset of the collection of learned variants to train a supervised learning framework; and assessing the pathogenicity of the unknown variant based on the trained supervised learning framework.

### Claim 19 (depends on 18)

The computer-implemented method of claim 18, further comprising: comparing the set of side information corresponding to each of a subset of the collection of learned variants, wherein the set of side information corresponding to each subsets of the collection of learned variants is compared in relation to similarity scores associated with the subsets of the collection of learned variants.

### Claim 20 (depends on 18)

The computer-implemented method of claim 18, further comprising:
assessing the pathogenicity of the unknown variant in relation to the pathogenicity of a nearest variant further comprising:
determining at least one probability for the nearest variant in relation to pathogenic metrics based on a collection of learned variants, wherein the pathogenic metrics comprise a data representation of at least one genetic condition cluster for computing the at least one probability for the nearest variant; and
generating a combined representation of the at least one probability, wherein the combined representation is outputted with respect to the pathogenic metrics.

### Claim 21 (depends on 20)

The computer-implemented method of claim 20, further comprising:
at least one of
generating the combined representation by averaging the at least one probability for each variant of a subset of the collection of learned variants, in response to the subset of the collection of learned variants comprise two or more variants with equivalent similarity score such that the nearest variant cannot be determined; and
generating the combined representation using the supervised learning framework based on at least one probability for each variant of a subset of the collection of learned variants given the set of side information, wherein the supervised learning framework comprises one or more supervised prediction models.

### Claim 22 (depends on 10)

The computer-implemented method of claim 10, wherein the phenotypic information comprises phenotypic ontology associated with one or more diseases.

### Claim 23 (depends on 9)

The computer-implemented method of claim 9, wherein the one or more generative models are configured to decompose the data presentation of annotated data in relation to the pathogenic metrics.

### Claim 24 (depends on 9)

The computer-implemented of claim 9, wherein the one or more generative models comprise at least one formulation based on a matrix factorization algorithm.

### Claim 25 (depends on 1)

The computer-implemented method of claim 1, wherein the pathogenic metrics comprises at least one classification indicative of a degree of pathogenicity.

### Claim 26 (depends on 25)

The computer-implemented method of claim 25, wherein each of the at least one classification is associated with a different optimal set of the at least one genetic condition cluster.

### Claim 27 (depends on 1)

A computer-readable medium comprising computer-readable code or instructions stored thereon, which when executed on a processor, causes the processor to implement the computer-implemented method according to claim 1.

### Claim 28 (depends on 1)

A system comprising at least one circuitry that is configured to execute the computer-implemented method according to claim 1.

### Claim 29 (depends on 1)

An apparatus comprising a processor, a memory and a communication interface, the processor connected to the memory and communication interface, wherein the apparatus is adapted or configured to implement the computer-implemented method according to claim 1.

### Claim 30

An apparatus for determining pathogenicity of a variant for a patient, the apparatus comprising:
an input component configured to receive the variant;
a processing component configured to determine whether the variant is within a collection of learned variants;
a prediction component, in response to a determination that the variant is present in the collection of the learned variant, configured to generate at least one probability for the variant in relation to pathogenic metrics, wherein the pathogenic metrics comprise a data representation of at least one genetic condition cluster for determining the at least one probability for the variant; and
a display component configured to display the at least one probability for the variant with respect to the pathogenic metrics, wherein the at least one probability is normalised.

### Claim 31 (depends on 30)

The apparatus of claim 30, wherein the prediction component, in response to a determination that the variant is absent in the collection of the learned variant, configured to receive a set of side information, wherein the side information is used to identify, in relation to the variant, a nearest variant that is applied as the variant to generate the at least one probability.

### Claim 32 (depends on 30)

The apparatus of claim 30, wherein the input component configured to receive phenotypic information associated with the patient, wherein the phenotypic information is applied to adjust the at least one probability for the variant in relation to the at least one genetic condition cluster.

### Claim 33

A computer-implemented method for determining a probability distribution of pathogenicity for an unknown gene variant using a set of side information, the method comprising:
receiving the unknown variant of a patient, wherein the unknown variant is not identified in or is new to the collection of learned variants associated with a plurality of patients;
assessing the pathogenicity of the unknown gene variant by using a supervised learning framework based on the set of side information; and
determining the probability distribution of pathogenicity based on the assessment.

### Claim 34 (depends on 33)

The computer-implemented method of claim 33, further comprising:
computing a probability of the unknown variant associated with a set of pathogenic metrics given the set of side information.

### Claim 35 (depends on 33)

The computer-implemented method of claim 33, further comprising:
determining at least one probability for the unknown variant in relation to pathogenic metrics based on a collection of learned variants; and
generating a combined representation of the at least one probability, wherein the combined representation is outputted with respect to the pathogenic metrics.

### Claim 36 (depends on 33)

The computer-implemented method of claim 33, wherein the supervised learning framework comprises one or more prediction models.

### Claim 37 (depends on 33)

The computer-implemented method of claim 33, wherein the supervised learning framework comprises a non-parametric classifier.

### Claim 38 (depends on 33)

The computer-implemented method of claim 33, wherein the set of side information is associated with the unknown gene variant.

### Claim 39 (depends on 33)

A computer-readable medium comprising computer-readable code or instructions stored thereon, which when executed on a processor, causes the processor to implement the computer-implemented method of claim 33.

### Claim 40 (depends on 2)

The computer-implemented method of claim 2, wherein the phenotypic information comprises phenotypic ontology associated with one or more diseases.

### Claim 41 (depends on 33)

An apparatus comprising a processor, a memory and a communication interface, the processor connected to the memory and communication interface, wherein the apparatus is adapted or configured to implement the computer-implemented method according to claim 33.
